Patent
The 2015 Annual Life Sciences Report
August 25 by Pharmaceuticals & Biotechnology EditorAccording to JLL’s latest annual life sciences report, advancement within medicines and global demographic trends are signalling the general strengthening of the life sciences industry. [inl...
Top Five Global Patent Concerns for 2015
August 19 by Pharmaceuticals & Biotechnology EditorIP professionals are constantly being pulled in different directions. In today’s global markets, it is crucial to understand international legal frameworks across a wide range of di...
Intellectual Property in the Global Marketplace: An Industry Investigation - 2014
August 07 by Pharmaceuticals & Biotechnology Editor89.7% of professionals in industry believe that intellectual property is and will be significant for them in 2014. In April and May 2014, we conducted Global Patent 2014 Survey. We surveyed&nbs...
Clinical Research “Likely to Return to the UK” Following Change in Patent Law
February 26 by Cold Chain IQ NewsComment from Intellectual Property specialists Marks & Clerk on the Government decision to exempt clinical and field trials from patent infringement - The UK Government has today announced pla...
Survey: Global Patent Congress 2012
May 11 by Pharma IQ SurveysIn preparation for the Global Patent Congress 2012, I would like to invite you to take part in a short survey, which aims to assess the current industry trends and challenges. The survey consists...
Pharma IQ Releases a New Podcast: How to Address the IP Issues Specifically Associated with Polymorphic Forms
November 17 by Pharma IQ NewsPharma IQ have just made a great new podcast interview available on the Resource Centre; How to Address the IP Issues Specifically Associated with Polymorphic Forms. The podcast is an interview w...
How to Address the IP Issues Specifically Associated with Polymorphic Forms
September 28 by Pharma IQIt is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutica...
The Challenges of Patenting in Pharma: Interview with Eric Ruhlmann, Actelion Pharmaceuticals
April 19 by Eric RuhlmannEric Ruhlmann, European Patent Attorney Director, Senior Patent Counsel, Legal Department, Actelion Pharmaceuticals Ltd, joins Pharma IQ, to discuss the latest challenges for patenting pharmaceutic...
Pharmaceutical and Biotech Patent Ligitation: An Interview with Vineet Kohli, Merck
April 19 by Richard de SilvaVineet Kohli, Assistant Patent Counsel at Merck & Co., Inc., reflects on the recent impacts in the law in regards to patenting antibodies, and developments for the strategies of internal busines...